Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 3
2003 4
2004 4
2005 2
2006 4
2007 5
2008 6
2009 9
2010 4
2011 8
2012 3
2013 4
2014 1
2015 1
2016 4
2017 3
2018 2
2019 6
2020 7
2021 7
2022 2
2023 5
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

82 results

Results by year

Filters applied: . Clear all
Page 1
Efficacy and safety of avacincaptad pegol in patients with geographic atrophy (GATHER2): 12-month results from a randomised, double-masked, phase 3 trial.
Khanani AM, Patel SS, Staurenghi G, Tadayoni R, Danzig CJ, Eichenbaum DA, Hsu J, Wykoff CC, Heier JS, Lally DR, Monés J, Nielsen JS, Sheth VS, Kaiser PK, Clark J, Zhu L, Patel H, Tang J, Desai D, Jaffe GJ; GATHER2 trial investigators. Khanani AM, et al. Lancet. 2023 Oct 21;402(10411):1449-1458. doi: 10.1016/S0140-6736(23)01583-0. Epub 2023 Sep 8. Lancet. 2023. PMID: 37696275
Central Serous Chorioretinopathy: Pathogenesis and Management.
Semeraro F, Morescalchi F, Russo A, Gambicorti E, Pilotto A, Parmeggiani F, Bartollino S, Costagliola C. Semeraro F, et al. Among authors: parmeggiani f. Clin Ophthalmol. 2019 Dec 2;13:2341-2352. doi: 10.2147/OPTH.S220845. eCollection 2019. Clin Ophthalmol. 2019. PMID: 31819359 Free PMC article. Review.
X-Chromosome Insight for Targeting Gene Therapy.
Parmeggiani F. Parmeggiani F. Ophthalmol Retina. 2020 May;4(5):521-522. doi: 10.1016/j.oret.2020.01.005. Ophthalmol Retina. 2020. PMID: 32381254 No abstract available.
Application of Artificial Intelligence in Targeting Retinal Diseases.
Sorrentino FS, Jurman G, De Nadai K, Campa C, Furlanello C, Parmeggiani F. Sorrentino FS, et al. Among authors: parmeggiani f. Curr Drug Targets. 2020;21(12):1208-1215. doi: 10.2174/1389450121666200708120646. Curr Drug Targets. 2020. PMID: 32640954 Review.
Topical nonsteroidal anti-inflammatory drugs for macular edema.
Russo A, Costagliola C, Delcassi L, Parmeggiani F, Romano MR, Dell'Omo R, Semeraro F. Russo A, et al. Among authors: parmeggiani f. Mediators Inflamm. 2013;2013:476525. doi: 10.1155/2013/476525. Epub 2013 Oct 21. Mediators Inflamm. 2013. PMID: 24227908 Free PMC article. Review.
Genetic predictors of response to photodynamictherapy.
Parmeggiani F, Gemmati D, Costagliola C, Semeraro F, Perri P, D'Angelo S, Romano MR, De Nadai K, Sebastiani A, Incorvaia C. Parmeggiani F, et al. Mol Diagn Ther. 2011 Aug 1;15(4):195-210. doi: 10.1007/BF03256411. Mol Diagn Ther. 2011. PMID: 21913742 Review.
Mechanism of inflammation in age-related macular degeneration.
Parmeggiani F, Romano MR, Costagliola C, Semeraro F, Incorvaia C, D'Angelo S, Perri P, De Palma P, De Nadai K, Sebastiani A. Parmeggiani F, et al. Mediators Inflamm. 2012;2012:546786. doi: 10.1155/2012/546786. Epub 2012 Nov 7. Mediators Inflamm. 2012. PMID: 23209345 Free PMC article. Review.
82 results